Panacea Biotec Products and Vaccines

Panacea Biotec

Country: India

Panacea Biotec Limited is an Indian biotechnology and pharmaceutical company headquartered in New Delhi. It was founded in 1984 as Panacea Drugs and listed in 1995 as Panacea Biotec. Its shares trade on India's NSE and BSE stock exchanges.

Vaccines are one of its main areas. In 2005 Panacea Biotec launched EasyFive in India, a fully liquid pentavalent vaccine against diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b, which was prequalified by the WHO in 2008. The company has also worked on polio vaccines, and in 2024, together with the Indian Council of Medical Research (ICMR), it started a phase III trial of its dengue vaccine DengiAll.

In oncology the company is known for PacliALL, launched in India in 2011. It is paclitaxel in albumin-bound nanoparticles (under 150 nm), which Panacea Biotec presented as the world's first generic of Abraxane. This form is infused faster than conventional paclitaxel and does not require premedication. In 2022 the company sold its branded formulations for India and Nepal to Mankind Pharma as part of a plan to become debt-free and focus on exports.

Unifarm carries Panacea Biotec's oncology medicine PacliALL (nab-paclitaxel).

Official manufacturer website
Panacea Biotec

List of medicines by manufacturer Panacea Biotec

✅ All products loaded (1)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00